TC BioPharm
Accelerating development of innovative cell-based products to treat disease and improve quality of life
Edinburgh, United Kingdom
10 - 50 Employees
High Level Pitch
Commencing operations in February 2014, TC BioPharm is a clinical development company with a cell-based product pipeline capable of treating a variety of disorders including cancer and severe viral infections.

Having raised equity funds from UK and Japanese investors, the company aims to commence phase II/III clinical studies in melanoma, renal cell carcinoma and lung cancer patients mid-2015.